Drug comparisons
Vildagliptin vs Insulin Icodec
Comparing Vildagliptin and Insulin Icodec: Vildagliptin is an oral DPP-4 inhibitor, while Insulin Icodec is a long-acting insulin. Details on how they work and who they suit.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes often compare Vildagliptin, a DPP-4 inhibitor, to Insulin Icodec, a long-acting insulin analog, when deciding on treatment options.
Bottom line
Both medications are effective for managing diabetes but the better one for you depends on your specific health situation.
All medication comparisons